beta

ADMA

ADMA Biologics Inc

Adma

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

11-08-2018 08-10-2018 05-14-2018 03-05-2018 11-03-2017 08-11-2017 05-12-2017
Actual EPS -0.33 -0.35 -0.35 -0.24 0.59 -0.55 -0.51
Consensus EPS -0.33 -0.32 -0.27 -0.51 -0.51 -0.42 -0.22
Estimated EPS -0.33 -0.32 -0.27 -0.51 -0.51 -0.42 -0.22
Number of Estimates 4 3 1 2 2 2 1
EPS Surprise -$0.03 -$0.08 $0.27 $1.10 -$0.13 -$0.29

Stats

Summary

ADMA Biologics Inc is a biopharmaceutical company. The Company develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases.

Market Cap: 179 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.admabiologics.com

Shares Outstanding: 45.3 Million

Float: 45.2 Million

Dividend: 0.0 (0.0%)

Beta: 2.264817

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 146 Thousand

Ethical Flags

Animal testing

Longest drawdown: 1032 trading days

From: 2014-11-06 To: 2018-12-14

Lowest Point:

Key events next week - healthcare

via: SeekingAlpha at 2018-12-14 09:54:28:000

Noteworthy events during the week of December 16 - 22 for healthcare investors. More news on: Innovate Biopharmaceuticals, Inc., Achillion Pharmaceuticals, Inc., ADMA Biologics Inc, Healthcare stocks news, , Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-12-14 09:54:28:000

Noteworthy events during the week of December 16 - 22 for healthcare investors. More news on: Innovate Biopharmaceuticals, Inc., Achillion Pharmaceuticals, Inc., ADMA Biologics Inc, Healthcare stocks news, , Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-12-14 09:54:28:000

Noteworthy events during the week of December 16 - 22 for healthcare investors. More news on: Innovate Biopharmaceuticals, Inc., Achillion Pharmaceuticals, Inc., ADMA Biologics Inc, Healthcare stocks news, , Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-12-14 09:54:28:000

Noteworthy events during the week of December 16 - 22 for healthcare investors. More news on: Innovate Biopharmaceuticals, Inc., Achillion Pharmaceuticals, Inc., ADMA Biologics Inc, Healthcare stocks news, , Read more … read more...

ADMA Biologics: Underfollowed And Undervalued Before Bivigam PDUFA

via: SeekingAlpha at 2018-12-13 13:10:24:000

ADMA Biologics ( ADMA ) has been on my watch list for over a year now, and the market has provided potential investors an opportunity to enter at a discount price. Unfortunately, the company has been at a discount for quite some time due to some regulatory setbacks. Still, I believe the compan… read more...

ADMA Biologics misses by $0.03, misses on revenue

via: SeekingAlpha at 2018-11-08 17:12:14:000

ADMA Biologics (NASDAQ: ADMA ): Q3 GAAP EPS of -$0.33 misses by $0.03 . Revenue of $4.23M (-10.6% Y/Y) misses by $0.72M . Press Release More news on: ADMA Biologics Inc, Earnings news and commentary, Healthcare stocks news, read more...

ADMA Biologics misses by $0.03, misses on revenue

via: SeekingAlpha at 2018-11-08 17:12:14:000

ADMA Biologics (NASDAQ: ADMA ): Q3 GAAP EPS of -$0.33 misses by $0.03 . Revenue of $4.23M (-10.6% Y/Y) misses by $0.72M . Press Release More news on: ADMA Biologics Inc, Earnings news and commentary, Healthcare stocks news, read more...

ADMA Biologics misses by $0.03, misses on revenue

via: SeekingAlpha at 2018-11-08 17:12:14:000

ADMA Biologics (NASDAQ: ADMA ): Q3 GAAP EPS of -$0.33 misses by $0.03 . Revenue of $4.23M (-10.6% Y/Y) misses by $0.72M . Press Release More news on: ADMA Biologics Inc, Earnings news and commentary, Healthcare stocks news, read more...

FDA accepts ADMA Bio's refiled marketing application for RI-002, action date April 2, 2019

via: SeekingAlpha at 2018-10-17 07:52:00:000

The FDA has accepted for review ADMA Biologics' (NASDAQ: ADMA ) resubmitted BLA seeking approval for lead candidate RI-002 for the treatment of patients with primary immune deficiency disease (PIDD). It received a CRL in July 2016 in response to its original filing. More news on: ADMA Bi… read more...

FDA accepts ADMA Bio's refiled marketing application for RI-002, action date April 2, 2019

via: SeekingAlpha at 2018-10-17 07:52:00:000

The FDA has accepted for review ADMA Biologics' (NASDAQ: ADMA ) resubmitted BLA seeking approval for lead candidate RI-002 for the treatment of patients with primary immune deficiency disease (PIDD). It received a CRL in July 2016 in response to its original filing. More news on: ADMA Bi… read more...

FDA accepts ADMA Bio's refiled marketing application for RI-002, action date April 2, 2019

via: SeekingAlpha at 2018-10-17 07:52:00:000

The FDA has accepted for review ADMA Biologics' (NASDAQ: ADMA ) resubmitted BLA seeking approval for lead candidate RI-002 for the treatment of patients with primary immune deficiency disease (PIDD). It received a CRL in July 2016 in response to its original filing. More news on: ADMA Bi… read more...

ADMA BioCenters receives FDA approval for third plasma collection center

via: SeekingAlpha at 2018-10-03 07:29:12:000

ADMA Biologics (NASDAQ: ADMA ) announces that the Companys wholly-owned subsidiary, ADMA BioCenters, has received FDA approval for its third plasma collection center, located at 166 Ernest W Barrett Parkway, NW, Marietta, Georgia. More news on: ADMA Biologics Inc, Dominion Energy… read more...

ADMA BioCenters receives FDA approval for third plasma collection center

via: SeekingAlpha at 2018-10-03 07:29:12:000

ADMA Biologics (NASDAQ: ADMA ) announces that the Companys wholly-owned subsidiary, ADMA BioCenters, has received FDA approval for its third plasma collection center, located at 166 Ernest W Barrett Parkway, NW, Marietta, Georgia. More news on: ADMA Biologics Inc, Dominion Energy… read more...

ADMA BioCenters receives FDA approval for third plasma collection center

via: SeekingAlpha at 2018-10-03 07:29:12:000

ADMA Biologics (NASDAQ: ADMA ) announces that the Companys wholly-owned subsidiary, ADMA BioCenters, has received FDA approval for its third plasma collection center, located at 166 Ernest W Barrett Parkway, NW, Marietta, Georgia. More news on: ADMA Biologics Inc, Dominion Energy… read more...

ADMA Biologics resubmits BLA for RI-002

via: SeekingAlpha at 2018-10-01 09:04:25:000

ADMA Biologics (NASDAQ: ADMA ) has responded to the July 2016 Complete Response Letter (CRL) and resubmitted its Biologics License Application (BLA) for RI-002 to the FDA on September 28, 2018. More news on: ADMA Biologics Inc, Healthcare stocks news, Stoc… read more...

ADMA Biologics resubmits BLA for RI-002

via: SeekingAlpha at 2018-10-01 09:04:25:000

ADMA Biologics (NASDAQ: ADMA ) has responded to the July 2016 Complete Response Letter (CRL) and resubmitted its Biologics License Application (BLA) for RI-002 to the FDA on September 28, 2018. More news on: ADMA Biologics Inc, Healthcare stocks news, Stoc… read more...

ADMA Biologics: Finish Line Ahead?

via: SeekingAlpha at 2018-09-06 11:59:22:000

"Revolution is a spectator sport. The majority will sit in the stands and watch the factions fight. At the end they will choose sides with the team that is winning." - George Lincoln Rockwell Today, we look at a "Busted IPO" that has caused its shareholders angina over the past year due to… read more...

ADMA Biologics: Finish Line Ahead?

via: SeekingAlpha at 2018-09-06 11:59:22:000

"Revolution is a spectator sport. The majority will sit in the stands and watch the factions fight. At the end they will choose sides with the team that is winning." - George Lincoln Rockwell Today, we look at a "Busted IPO" that has caused its shareholders angina over the past year due to… read more...

ADMA Biologics: Finish Line Ahead?

via: SeekingAlpha at 2018-09-06 11:59:22:000

"Revolution is a spectator sport. The majority will sit in the stands and watch the factions fight. At the end they will choose sides with the team that is winning." - George Lincoln Rockwell Today, we look at a "Busted IPO" that has caused its shareholders angina over the past year due to… read more...

ADMA Biologics: Buy Or Sell Before Bivigam PDUFA?

via: SeekingAlpha at 2018-08-30 23:34:06:000

ADMA Biologics (ADMA) shares are already up 10% in less than a week since the trade was mentioned to subscribers of the premium Marketplace service. They have more upside ahead. (Source: Finviz) Investment thesis Catalyst: PDUFA for BIVIGAM (iv immunoglobulin) in treating primary humoral… read more...

ADMA Biologics: Buy Or Sell Before Bivigam PDUFA?

via: SeekingAlpha at 2018-08-30 23:34:06:000

ADMA Biologics (ADMA) shares are already up 10% in less than a week since the trade was mentioned to subscribers of the premium Marketplace service. They have more upside ahead. (Source: Finviz) Investment thesis Catalyst: PDUFA for BIVIGAM (iv immunoglobulin) in treating primary humoral… read more...

ADMA Biologics: Buy Or Sell Before Bivigam PDUFA?

via: SeekingAlpha at 2018-08-30 23:34:06:000

ADMA Biologics (ADMA) shares are already up 10% in less than a week since the trade was mentioned to subscribers of the premium Marketplace service. They have more upside ahead. (Source: Finviz) Investment thesis Catalyst: PDUFA for BIVIGAM (iv immunoglobulin) in treating primary humoral… read more...

ADMA Biologics: Buy Or Sell Before Bivigam PDUFA?

via: SeekingAlpha at 2018-08-30 23:34:06:000

ADMA Biologics (ADMA) shares are already up 10% in less than a week since the trade was mentioned to subscribers of the premium Marketplace service. They have more upside ahead. (Source: Finviz) Investment thesis Catalyst: PDUFA for BIVIGAM (iv immunoglobulin) in treating primary humoral… read more...

ADMA Biologics: Buy Or Sell Before Bivigam PDUFA?

via: SeekingAlpha at 2018-08-30 23:34:06:000

ADMA Biologics (ADMA) shares are already up 10% in less than a week since the trade was mentioned to subscribers of the premium Marketplace service. They have more upside ahead. (Source: Finviz) Investment thesis Catalyst: PDUFA for BIVIGAM (iv immunoglobulin) in treating primary humoral… read more...

ADMA Biologics: Buy Or Sell Before Bivigam PDUFA?

via: SeekingAlpha at 2018-08-30 23:34:06:000

ADMA Biologics (ADMA) shares are already up 10% in less than a week since the trade was mentioned to subscribers of the premium Marketplace service. They have more upside ahead. (Source: Finviz) Investment thesis Catalyst: PDUFA for BIVIGAM (iv immunoglobulin) in treating primary humoral… read more...

Revisiting ADMA Biologics

via: SeekingAlpha at 2018-08-23 20:28:26:000

Anger based on calculated reason is more dangerous than anger based on blind hate - Richelle Mead, Last Sacrifice Today we revisit a 'Busted IPO' that has had a challenging year but could see brighter horizons in the months ahead. Company Overview: ADMA Biologics, Inc. ( A… read more...

Revisiting ADMA Biologics

via: SeekingAlpha at 2018-08-23 20:28:26:000

Anger based on calculated reason is more dangerous than anger based on blind hate - Richelle Mead, Last Sacrifice Today we revisit a 'Busted IPO' that has had a challenging year but could see brighter horizons in the months ahead. Company Overview: ADMA Biologics, Inc. ( A… read more...

Revisiting ADMA Biologics

via: SeekingAlpha at 2018-08-23 20:28:26:000

Anger based on calculated reason is more dangerous than anger based on blind hate - Richelle Mead, Last Sacrifice Today we revisit a 'Busted IPO' that has had a challenging year but could see brighter horizons in the months ahead. Company Overview: ADMA Biologics, Inc. ( A… read more...

Revisiting ADMA Biologics

via: SeekingAlpha at 2018-08-23 20:28:26:000

Anger based on calculated reason is more dangerous than anger based on blind hate - Richelle Mead, Last Sacrifice Today we revisit a 'Busted IPO' that has had a challenging year but could see brighter horizons in the months ahead. Company Overview: ADMA Biologics, Inc. ( A… read more...

Revisiting ADMA Biologics

via: SeekingAlpha at 2018-08-23 20:28:26:000

Anger based on calculated reason is more dangerous than anger based on blind hate - Richelle Mead, Last Sacrifice Today we revisit a 'Busted IPO' that has had a challenging year but could see brighter horizons in the months ahead. Company Overview: ADMA Biologics, Inc. ( A… read more...

ADMA Biologics Q2 revenues up 38%

via: SeekingAlpha at 2018-08-10 07:55:21:000

ADMA Biologics ( ADMA ) Q2 results : Revenues: $4.7M (+38.2%); Product revenue: $4.6M (+35.3%); License and other revenue: $0.04M (unch). More news on: ADMA Biologics Inc, Healthcare stocks news, Earnings news and commentary, Read more … read more...

ADMA Biologics Q2 revenues up 38%

via: SeekingAlpha at 2018-08-10 07:55:21:000

ADMA Biologics ( ADMA ) Q2 results : Revenues: $4.7M (+38.2%); Product revenue: $4.6M (+35.3%); License and other revenue: $0.04M (unch). More news on: ADMA Biologics Inc, Healthcare stocks news, Earnings news and commentary, Read more … read more...

ADMA Biologics Q2 revenues up 38%

via: SeekingAlpha at 2018-08-10 07:55:21:000

ADMA Biologics ( ADMA ) Q2 results : Revenues: $4.7M (+38.2%); Product revenue: $4.6M (+35.3%); License and other revenue: $0.04M (unch). More news on: ADMA Biologics Inc, Healthcare stocks news, Earnings news and commentary, Read more … read more...

ADMA Biologics Q2 revenues up 38%

via: SeekingAlpha at 2018-08-10 07:55:21:000

ADMA Biologics ( ADMA ) Q2 results : Revenues: $4.7M (+38.2%); Product revenue: $4.6M (+35.3%); License and other revenue: $0.04M (unch). More news on: ADMA Biologics Inc, Healthcare stocks news, Earnings news and commentary, Read more … read more...

ADMA Biologics Q2 revenues up 38%

via: SeekingAlpha at 2018-08-10 07:55:21:000

ADMA Biologics ( ADMA ) Q2 results : Revenues: $4.7M (+38.2%); Product revenue: $4.6M (+35.3%); License and other revenue: $0.04M (unch). More news on: ADMA Biologics Inc, Healthcare stocks news, Earnings news and commentary, Read more … read more...

ADMA Biologics misses by $0.04, misses on revenue

via: SeekingAlpha at 2018-08-10 07:12:22:000

ADMA Biologics (NASDAQ: ADMA ): Q2 EPS of -$0.35 misses by $0.04 . More news on: ADMA Biologics Inc, Earnings news and commentary, Healthcare stocks news, Read more … read more...

ADMA Biologics misses by $0.04, misses on revenue

via: SeekingAlpha at 2018-08-10 07:12:22:000

ADMA Biologics (NASDAQ: ADMA ): Q2 EPS of -$0.35 misses by $0.04 . More news on: ADMA Biologics Inc, Earnings news and commentary, Healthcare stocks news, Read more … read more...

ADMA Biologics misses by $0.04, misses on revenue

via: SeekingAlpha at 2018-08-10 07:12:22:000

ADMA Biologics (NASDAQ: ADMA ): Q2 EPS of -$0.35 misses by $0.04 . More news on: ADMA Biologics Inc, Earnings news and commentary, Healthcare stocks news, Read more … read more...

ADMA Biologics misses by $0.04, misses on revenue

via: SeekingAlpha at 2018-08-10 07:12:22:000

ADMA Biologics (NASDAQ: ADMA ): Q2 EPS of -$0.35 misses by $0.04 . More news on: ADMA Biologics Inc, Earnings news and commentary, Healthcare stocks news, Read more … read more...

ADMA Biologics misses by $0.04, misses on revenue

via: SeekingAlpha at 2018-08-10 07:12:22:000

ADMA Biologics (NASDAQ: ADMA ): Q2 EPS of -$0.35 misses by $0.04 . More news on: ADMA Biologics Inc, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2018-07-30 08:28:52:000

ADMA Biologics (NASDAQ: ADMA ) initiated with Buy rating and $10 (64% upside) price target at Chardan. More news on: ADMA Biologics Inc, Galapagos, Apellis Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2018-07-30 08:28:52:000

ADMA Biologics (NASDAQ: ADMA ) initiated with Buy rating and $10 (64% upside) price target at Chardan. More news on: ADMA Biologics Inc, Galapagos, Apellis Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2018-07-30 08:28:52:000

ADMA Biologics (NASDAQ: ADMA ) initiated with Buy rating and $10 (64% upside) price target at Chardan. More news on: ADMA Biologics Inc, Galapagos, Apellis Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...

Your Daily Pharma Scoop: ADMA Closer To PDUFA, Roche Proceeds, AstraZeneca Flunks

via: SeekingAlpha at 2018-07-30 00:21:18:000

Stocks in News: ADMA, RHHBY FDA accepts ADMA Bio's Bivigam application amendment, action date October 25; shares up 18% Discussion : ADMA Biologics ( ADMA ) announced that its request for amendment to BLA to relaunch BIVIGAM (intravenous immune globulin [human], 10%). PDUFA is on Octo… read more...

Your Daily Pharma Scoop: ADMA Closer To PDUFA, Roche Proceeds, AstraZeneca Flunks

via: SeekingAlpha at 2018-07-30 00:21:18:000

Stocks in News: ADMA, RHHBY FDA accepts ADMA Bio's Bivigam application amendment, action date October 25; shares up 18% Discussion : ADMA Biologics ( ADMA ) announced that its request for amendment to BLA to relaunch BIVIGAM (intravenous immune globulin [human], 10%). PDUFA is on Octo… read more...

Your Daily Pharma Scoop: ADMA Closer To PDUFA, Roche Proceeds, AstraZeneca Flunks

via: SeekingAlpha at 2018-07-30 00:21:18:000

Stocks in News: ADMA, RHHBY FDA accepts ADMA Bio's Bivigam application amendment, action date October 25; shares up 18% Discussion : ADMA Biologics ( ADMA ) announced that its request for amendment to BLA to relaunch BIVIGAM (intravenous immune globulin [human], 10%). PDUFA is on Octo… read more...

Midday Gainers / Losers (07/26/2018)

via: SeekingAlpha at 2018-07-26 12:40:18:000

Gainers: BSPM +105% . SVU +64% . BPI +50% . PCMI +26% . JBT +22% . AWX +20% . ANIK +18% . MTSL +15% . ADMA +17% . KODK +17% . More news on: Biostar Pharmaceutic, SUPERVALU Inc., Bridgepoint Education, Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (07/26/2018)

via: SeekingAlpha at 2018-07-26 12:40:18:000

Gainers: BSPM +105% . SVU +64% . BPI +50% . PCMI +26% . JBT +22% . AWX +20% . ANIK +18% . MTSL +15% . ADMA +17% . KODK +17% . More news on: Biostar Pharmaceutic, SUPERVALU Inc., Bridgepoint Education, Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (07/26/2018)

via: SeekingAlpha at 2018-07-26 12:40:18:000

Gainers: BSPM +105% . SVU +64% . BPI +50% . PCMI +26% . JBT +22% . AWX +20% . ANIK +18% . MTSL +15% . ADMA +17% . KODK +17% . More news on: Biostar Pharmaceutic, SUPERVALU Inc., Bridgepoint Education, Inc., Stocks on the move, , Read more … read more...

FDA accepts ADMA Bio's Bivigam application amendment, action date October 25; shares up 18%

via: SeekingAlpha at 2018-07-26 10:08:13:000

Thinly traded micro cap ADMA Biologics ( ADMA +17.6% ) is up almost double normal volume on the heels of its announcement that the FDA has accepted for review its BLA amendment seeking approval to relaunch BIVIGAM (intravenous immune globulin [human], 10%). The agency's action date is Oc… read more...

FDA accepts ADMA Bio's Bivigam application amendment, action date October 25; shares up 18%

via: SeekingAlpha at 2018-07-26 10:08:13:000

Thinly traded micro cap ADMA Biologics ( ADMA +17.6% ) is up almost double normal volume on the heels of its announcement that the FDA has accepted for review its BLA amendment seeking approval to relaunch BIVIGAM (intravenous immune globulin [human], 10%). The agency's action date is Oc… read more...

FDA accepts ADMA Bio's Bivigam application amendment, action date October 25; shares up 18%

via: SeekingAlpha at 2018-07-26 10:08:13:000

Thinly traded micro cap ADMA Biologics ( ADMA +17.6% ) is up almost double normal volume on the heels of its announcement that the FDA has accepted for review its BLA amendment seeking approval to relaunch BIVIGAM (intravenous immune globulin [human], 10%). The agency's action date is Oc… read more...

Premarket Gainers as of 9:05 am (07/26/2018)

via: SeekingAlpha at 2018-07-26 09:15:09:000

SVU +65% on Q1 result . More news on: SUPERVALU Inc., Bridgepoint Education, Inc., Taoping Inc, , Stocks on the move, Read more … read more...

Premarket Gainers as of 9:05 am (07/26/2018)

via: SeekingAlpha at 2018-07-26 09:15:09:000

SVU +65% on Q1 result . More news on: SUPERVALU Inc., Bridgepoint Education, Inc., Taoping Inc, , Stocks on the move, Read more … read more...

Premarket Gainers as of 9:05 am (07/26/2018)

via: SeekingAlpha at 2018-07-26 09:15:09:000

SVU +65% on Q1 result . More news on: SUPERVALU Inc., Bridgepoint Education, Inc., Taoping Inc, , Stocks on the move, Read more … read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2018-07-13 07:30:54:000

AcelRx Pharmaceuticals (NASDAQ: ACRX ) initiated with Market Perform rating at Oppenheimer. More news on: AcelRx Pharmaceuticals, Inc., ADMA Biologics Inc, Avenue Therapeutics, Healthcare stocks news, Stocks on the move, , Read more … read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2018-07-13 07:30:54:000

AcelRx Pharmaceuticals (NASDAQ: ACRX ) initiated with Market Perform rating at Oppenheimer. More news on: AcelRx Pharmaceuticals, Inc., ADMA Biologics Inc, Avenue Therapeutics, Healthcare stocks news, Stocks on the move, , Read more … read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2018-07-13 07:30:54:000

AcelRx Pharmaceuticals (NASDAQ: ACRX ) initiated with Market Perform rating at Oppenheimer. More news on: AcelRx Pharmaceuticals, Inc., ADMA Biologics Inc, Avenue Therapeutics, Healthcare stocks news, Stocks on the move, , Read more … read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2018-07-13 07:30:54:000

AcelRx Pharmaceuticals (NASDAQ: ACRX ) initiated with Market Perform rating at Oppenheimer. More news on: AcelRx Pharmaceuticals, Inc., ADMA Biologics Inc, Avenue Therapeutics, Healthcare stocks news, Stocks on the move, , Read more … read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2018-07-13 07:30:54:000

AcelRx Pharmaceuticals (NASDAQ: ACRX ) initiated with Market Perform rating at Oppenheimer. More news on: AcelRx Pharmaceuticals, Inc., ADMA Biologics Inc, Avenue Therapeutics, Healthcare stocks news, Stocks on the move, , Read more … read more...

Healthcare names joining Russell indexes today

via: SeekingAlpha at 2018-06-25 07:20:14:000

ADMA Biologics (NASDAQ: ADMA ) added to Russell 3000 and Russell 2000 More news on: ADMA Biologics Inc, Helius Medical Technologies, Inc., GTx, Inc., Healthcare stocks news, Read more … read more...

Healthcare names joining Russell indexes today

via: SeekingAlpha at 2018-06-25 07:20:14:000

ADMA Biologics (NASDAQ: ADMA ) added to Russell 3000 and Russell 2000 More news on: ADMA Biologics Inc, Helius Medical Technologies, Inc., GTx, Inc., Healthcare stocks news, Read more … read more...

Healthcare names joining Russell indexes today

via: SeekingAlpha at 2018-06-25 07:20:14:000

ADMA Biologics (NASDAQ: ADMA ) added to Russell 3000 and Russell 2000 More news on: ADMA Biologics Inc, Helius Medical Technologies, Inc., GTx, Inc., Healthcare stocks news, Read more … read more...

Rounds Report: Versartis Rallied Due To Strong Turnaround Progress

via: SeekingAlpha at 2018-06-15 04:59:27:000

How is the company supposed to be turning around? Has it rid itself of unprofitable divisions? This can make a big difference in earnings. For example, in 1980 Lockheed earned $8.04 per share from its defense business, but it lost $6.54 per share in its commercial aviation division because of… read more...

Rounds Report: Versartis Rallied Due To Strong Turnaround Progress

via: SeekingAlpha at 2018-06-15 04:59:27:000

How is the company supposed to be turning around? Has it rid itself of unprofitable divisions? This can make a big difference in earnings. For example, in 1980 Lockheed earned $8.04 per share from its defense business, but it lost $6.54 per share in its commercial aviation division because of… read more...

Rounds Report: Versartis Rallied Due To Strong Turnaround Progress

via: SeekingAlpha at 2018-06-15 04:59:27:000

How is the company supposed to be turning around? Has it rid itself of unprofitable divisions? This can make a big difference in earnings. For example, in 1980 Lockheed earned $8.04 per share from its defense business, but it lost $6.54 per share in its commercial aviation division because of… read more...

Rounds Report: Versartis Rallied Due To Strong Turnaround Progress

via: SeekingAlpha at 2018-06-15 04:59:27:000

How is the company supposed to be turning around? Has it rid itself of unprofitable divisions? This can make a big difference in earnings. For example, in 1980 Lockheed earned $8.04 per share from its defense business, but it lost $6.54 per share in its commercial aviation division because of… read more...

Rounds Report: Versartis Rallied Due To Strong Turnaround Progress

via: SeekingAlpha at 2018-06-15 04:59:27:000

How is the company supposed to be turning around? Has it rid itself of unprofitable divisions? This can make a big difference in earnings. For example, in 1980 Lockheed earned $8.04 per share from its defense business, but it lost $6.54 per share in its commercial aviation division because of… read more...

ADMA Biologics: The Right Way To Fix Manufacturing

via: SeekingAlpha at 2018-06-14 14:23:50:000

Overview ADMA is in the third inning of a corporate turn-around. A manufacturing-related Warning Letter is preventing ADMA from reintroducing Bivigam to the market ($60m Revs/yr) and getting FDA approval for RI-002 (could be a $200m+/yr). While ADMA management has stated that their facility … read more...

Your Daily Pharma Scoop: Secondaries Review June 4-11

via: SeekingAlpha at 2018-06-12 10:00:00:000

A discussion of secondary offerings provides interesting analysis of a company. There are two kinds of secondary offerings; one, the non-dilutive kind, where no new shares are issued, but a large institutional shareholder simply releases a large block of previously issued shares. Two, a diluti… read more...

Your Daily Pharma Scoop: Secondaries Review June 4-11

via: SeekingAlpha at 2018-06-12 10:00:00:000

A discussion of secondary offerings provides interesting analysis of a company. There are two kinds of secondary offerings; one, the non-dilutive kind, where no new shares are issued, but a large institutional shareholder simply releases a large block of previously issued shares. Two, a diluti… read more...

Insiders take down modest chunk of Adma Biologics offering

via: SeekingAlpha at 2018-06-11 12:32:45:000

Among the buyers were CEO Adam Grossman, board member Jerrold Grossman, CFO Brian Lenz, and board members Lawrence Guiheen and Eric Richman. More news on: ADMA Biologics Inc, Healthcare stocks news, Read more … read more...

ADMA Biologics granted U.S. Patent for treating respiratory infections

via: SeekingAlpha at 2018-05-16 08:42:40:000

United States Patent and Trademark Office has issued ADMA Biologics (NASDAQ: ADMA ) U.S. Patent No. 9,969,793 covering methods of treating respiratory infections. More news on: ADMA Biologics Inc, Healthcare stocks news, Read more … read more...

ADMA Biologics granted U.S. Patent for treating respiratory infections

via: SeekingAlpha at 2018-05-16 08:42:40:000

United States Patent and Trademark Office has issued ADMA Biologics (NASDAQ: ADMA ) U.S. Patent No. 9,969,793 covering methods of treating respiratory infections. More news on: ADMA Biologics Inc, Healthcare stocks news, Read more … read more...

ADMA Biologics granted U.S. Patent for treating respiratory infections

via: SeekingAlpha at 2018-05-16 08:42:40:000

United States Patent and Trademark Office has issued ADMA Biologics (NASDAQ: ADMA ) U.S. Patent No. 9,969,793 covering methods of treating respiratory infections. More news on: ADMA Biologics Inc, Healthcare stocks news, Read more … read more...

ADMA Biologics granted U.S. Patent for treating respiratory infections

via: SeekingAlpha at 2018-05-16 08:42:40:000

United States Patent and Trademark Office has issued ADMA Biologics (NASDAQ: ADMA ) U.S. Patent No. 9,969,793 covering methods of treating respiratory infections. More news on: ADMA Biologics Inc, Healthcare stocks news, Read more … read more...

ADMA Biologics granted U.S. Patent for treating respiratory infections

via: SeekingAlpha at 2018-05-16 08:42:40:000

United States Patent and Trademark Office has issued ADMA Biologics (NASDAQ: ADMA ) U.S. Patent No. 9,969,793 covering methods of treating respiratory infections. More news on: ADMA Biologics Inc, Healthcare stocks news, Read more … read more...

ADMA Biologics granted U.S. Patent for treating respiratory infections

via: SeekingAlpha at 2018-05-16 08:42:40:000

United States Patent and Trademark Office has issued ADMA Biologics (NASDAQ: ADMA ) U.S. Patent No. 9,969,793 covering methods of treating respiratory infections. More news on: ADMA Biologics Inc, Healthcare stocks news, Read more … read more...

ADMA Biologics granted U.S. Patent for treating respiratory infections

via: SeekingAlpha at 2018-05-16 08:42:40:000

United States Patent and Trademark Office has issued ADMA Biologics (NASDAQ: ADMA ) U.S. Patent No. 9,969,793 covering methods of treating respiratory infections. More news on: ADMA Biologics Inc, Healthcare stocks news, Read more … read more...

ADMA Biologics misses by $0.08, misses on revenue

via: SeekingAlpha at 2018-05-14 17:16:29:000

ADMA Biologics (NASDAQ: ADMA ): Q1 EPS of -$0.39 misses by $0.08 . More news on: ADMA Biologics Inc, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

ADMA Biologics misses by $0.08, misses on revenue

via: SeekingAlpha at 2018-05-14 17:16:29:000

ADMA Biologics (NASDAQ: ADMA ): Q1 EPS of -$0.39 misses by $0.08 . More news on: ADMA Biologics Inc, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

ADMA Bio retires 8.6M shares of stock issued to Biotest; shares up 10%

via: SeekingAlpha at 2018-05-14 14:08:26:000

ADMA Biologics ( ADMA +10.2% ) announces that it has negotiated the receipt and retirement of ~8.6M shares of its non-voting common stock previously issued to Biotest Pharmaceuticals (BPC) for its Therapy Business Unit (12.9M total ADMA shares issued). More news on: ADMA Biologics Inc,… read more...

ADMA Bio retires 8.6M shares of stock issued to Biotest; shares up 10%

via: SeekingAlpha at 2018-05-14 14:08:26:000

ADMA Biologics ( ADMA +10.2% ) announces that it has negotiated the receipt and retirement of ~8.6M shares of its non-voting common stock previously issued to Biotest Pharmaceuticals (BPC) for its Therapy Business Unit (12.9M total ADMA shares issued). More news on: ADMA Biologics Inc,… read more...

Institutional Top Ideas Series: Broadfin Capital

via: SeekingAlpha at 2018-04-05 12:11:42:000

In the last entry of this recently rebooted series, we took a look at top ideas from Deerfield Management (whose performance almost doubled that of the IBB during time frame we looked at). Keep in mind articles older than 10 days can only be accessed if you have a membership to ROTY or S… read more...

Institutional Top Ideas Series: Broadfin Capital

via: SeekingAlpha at 2018-04-05 12:11:42:000

In the last entry of this recently rebooted series, we took a look at top ideas from Deerfield Management (whose performance almost doubled that of the IBB during time frame we looked at). Keep in mind articles older than 10 days can only be accessed if you have a membership to ROTY or S… read more...

Institutional Top Ideas Series: Consonance Capital

via: SeekingAlpha at 2018-03-23 13:07:49:000

The last time I did this series was in August of last year, so it has been quite a while. In the past we took a look at portfolios of institutional investors of note, such as BVF, Opaleye, Great Point Partners, Consonance Capital and more. With this reboot, I hope to again delve into the po… read more...

Institutional Top Ideas Series: Consonance Capital

via: SeekingAlpha at 2018-03-23 13:07:49:000

The last time I did this series was in August of last year, so it has been quite a while. In the past we took a look at portfolios of institutional investors of note, such as BVF, Opaleye, Great Point Partners, Consonance Capital and more. With this reboot, I hope to again delve into the po… read more...

ADMA Biologics: Almost Ready To Run Between The Toes Of Giants

via: SeekingAlpha at 2018-03-06 07:36:21:000

1. Introduction to the Investment Thesis ADMA Biologics is a sub-$100m capitalization healthcare company that is based in Boca Raton, Florida. The company is aiming to commercialize a novel high-titer hyper-immune globulin product for the treatment of RSV and related respiratory viruses… read more...

ADMA Biologics: Almost Ready To Run Between The Toes Of Giants

via: SeekingAlpha at 2018-03-06 07:36:21:000

1. Introduction to the Investment Thesis ADMA Biologics is a sub-$100m capitalization healthcare company that is based in Boca Raton, Florida. The company is aiming to commercialize a novel high-titer hyper-immune globulin product for the treatment of RSV and related respiratory viruses… read more...

ADMA Biologics reports FY results

via: SeekingAlpha at 2018-03-05 07:11:59:000

ADMA Biologics (NASDAQ: ADMA ): FY EPS of -$1.91 More news on: ADMA Biologics Inc, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

ADMA Biologics reports FY results

via: SeekingAlpha at 2018-03-05 07:11:59:000

ADMA Biologics (NASDAQ: ADMA ): FY EPS of -$1.91 More news on: ADMA Biologics Inc, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-03-02 11:03:10:000

Noteworthy events for the week of March 4 - 10 for healthcare investors: More news on: Merck & Co Inc., Arena Pharmaceuticals, Inc., NeuroMetrix, Inc., Healthcare stocks news, Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-03-02 11:03:10:000

Noteworthy events for the week of March 4 - 10 for healthcare investors: More news on: Merck & Co Inc., Arena Pharmaceuticals, Inc., NeuroMetrix, Inc., Healthcare stocks news, Read more … read more...

Weekly Insider Trading, Feb 1

via: SeekingAlpha at 2018-02-02 10:15:25:000

Weekly Insider Trading, Feb 1 2018. Sorry about the silence the past couple of weeks, but this period of the year is in fact a silent period for so many companies that there has not been the normal level of insider activity to review. Even with a couple of weeks in the bag, after secondar… read more...

Weekly Insider Trading, Feb 1

via: SeekingAlpha at 2018-02-02 10:15:25:000

Weekly Insider Trading, Feb 1 2018. Sorry about the silence the past couple of weeks, but this period of the year is in fact a silent period for so many companies that there has not been the normal level of insider activity to review. Even with a couple of weeks in the bag, after secondar… read more...

Weekly Insider Trading, Feb 1

via: SeekingAlpha at 2018-02-02 10:15:25:000

Weekly Insider Trading, Feb 1 2018. Sorry about the silence the past couple of weeks, but this period of the year is in fact a silent period for so many companies that there has not been the normal level of insider activity to review. Even with a couple of weeks in the bag, after secondar… read more...

Weekly Insider Trading, Feb 1

via: SeekingAlpha at 2018-02-02 10:15:25:000

Weekly Insider Trading, Feb 1 2018. Sorry about the silence the past couple of weeks, but this period of the year is in fact a silent period for so many companies that there has not been the normal level of insider activity to review. Even with a couple of weeks in the bag, after secondar… read more...

Weekly Insider Trading, Feb 1

via: SeekingAlpha at 2018-02-02 10:15:25:000

Weekly Insider Trading, Feb 1 2018. Sorry about the silence the past couple of weeks, but this period of the year is in fact a silent period for so many companies that there has not been the normal level of insider activity to review. Even with a couple of weeks in the bag, after secondar… read more...

Week 4 Breakout Forecast: Short-Term Picks To Give You An Edge

via: SeekingAlpha at 2018-01-21 02:53:39:000

Breakout Forecast Selections for Week 4: This week I have selected two of the 8 breakout stocks to share from the subscription Breakout Portfolio. Healthcare biotechnology and technology stocks were the largest representation of breakout stocks in my screener for this week. Detailed chart… read more...

Week 4 Breakout Forecast: Short-Term Picks To Give You An Edge

via: SeekingAlpha at 2018-01-21 02:53:39:000

Breakout Forecast Selections for Week 4: This week I have selected two of the 8 breakout stocks to share from the subscription Breakout Portfolio. Healthcare biotechnology and technology stocks were the largest representation of breakout stocks in my screener for this week. Detailed chart… read more...

Week 4 Breakout Forecast: Short-Term Picks To Give You An Edge

via: SeekingAlpha at 2018-01-21 02:53:39:000

Breakout Forecast Selections for Week 4: This week I have selected two of the 8 breakout stocks to share from the subscription Breakout Portfolio. Healthcare biotechnology and technology stocks were the largest representation of breakout stocks in my screener for this week. Detailed chart… read more...

Week 4 Breakout Forecast: Short-Term Picks To Give You An Edge

via: SeekingAlpha at 2018-01-21 02:53:39:000

Breakout Forecast Selections for Week 4: This week I have selected two of the 8 breakout stocks to share from the subscription Breakout Portfolio. Healthcare biotechnology and technology stocks were the largest representation of breakout stocks in my screener for this week. Detailed chart… read more...

Week 4 Breakout Forecast: Short-Term Picks To Give You An Edge

via: SeekingAlpha at 2018-01-21 02:53:39:000

Breakout Forecast Selections for Week 4: This week I have selected two of the 8 breakout stocks to share from the subscription Breakout Portfolio. Healthcare biotechnology and technology stocks were the largest representation of breakout stocks in my screener for this week. Detailed chart… read more...

Week 3 Breakout Forecast:  Short-Term Picks To Give You An Edge

via: SeekingAlpha at 2018-01-13 12:44:46:000

Breakout Forecast Selections for Week 3: This week I have selected two of the 8 breakout stocks to share from the subscription Breakout Portfolio. Healthcare biotechnology and technology stocks were the largest representation of breakout stocks in my screener for this week. Detailed chart… read more...

Week 3 Breakout Forecast:  Short-Term Picks To Give You An Edge

via: SeekingAlpha at 2018-01-13 12:44:46:000

Breakout Forecast Selections for Week 3: This week I have selected two of the 8 breakout stocks to share from the subscription Breakout Portfolio. Healthcare biotechnology and technology stocks were the largest representation of breakout stocks in my screener for this week. Detailed chart… read more...

Week 3 Breakout Forecast:  Short-Term Picks To Give You An Edge

via: SeekingAlpha at 2018-01-13 12:44:46:000

Breakout Forecast Selections for Week 3: This week I have selected two of the 8 breakout stocks to share from the subscription Breakout Portfolio. Healthcare biotechnology and technology stocks were the largest representation of breakout stocks in my screener for this week. Detailed chart… read more...

Week 3 Breakout Forecast:  Short-Term Picks To Give You An Edge

via: SeekingAlpha at 2018-01-13 12:44:46:000

Breakout Forecast Selections for Week 3: This week I have selected two of the 8 breakout stocks to share from the subscription Breakout Portfolio. Healthcare biotechnology and technology stocks were the largest representation of breakout stocks in my screener for this week. Detailed chart… read more...

Week 3 Breakout Forecast:  Short-Term Picks To Give You An Edge

via: SeekingAlpha at 2018-01-13 12:44:46:000

Breakout Forecast Selections for Week 3: This week I have selected two of the 8 breakout stocks to share from the subscription Breakout Portfolio. Healthcare biotechnology and technology stocks were the largest representation of breakout stocks in my screener for this week. Detailed chart… read more...

Breakout Portfolio Up 14.38% Into 2018: Method Or Madness?

via: SeekingAlpha at 2018-01-11 21:29:26:000

Everything we care about lies somewhere in the middle, where pattern and randomness interlace. James Gleick , The Information: A History, a Theory, a Flood This chart is a canonical plot of seven distinct positive, negative, and neutral stock momentum grou… read more...

Breakout Portfolio Up 14.38% Into 2018: Method Or Madness?

via: SeekingAlpha at 2018-01-11 21:29:26:000

Everything we care about lies somewhere in the middle, where pattern and randomness interlace. James Gleick , The Information: A History, a Theory, a Flood This chart is a canonical plot of seven distinct positive, negative, and neutral stock momentum grou… read more...

Breakout Portfolio Up 14.38% Into 2018: Method Or Madness?

via: SeekingAlpha at 2018-01-11 21:29:26:000

Everything we care about lies somewhere in the middle, where pattern and randomness interlace. James Gleick , The Information: A History, a Theory, a Flood This chart is a canonical plot of seven distinct positive, negative, and neutral stock momentum grou… read more...

Breakout Portfolio Up 14.38% Into 2018: Method Or Madness?

via: SeekingAlpha at 2018-01-11 21:29:26:000

Everything we care about lies somewhere in the middle, where pattern and randomness interlace. James Gleick , The Information: A History, a Theory, a Flood This chart is a canonical plot of seven distinct positive, negative, and neutral stock momentum grou… read more...

Breakout Portfolio Up 14.38% Into 2018: Method Or Madness?

via: SeekingAlpha at 2018-01-11 21:29:26:000

Everything we care about lies somewhere in the middle, where pattern and randomness interlace. James Gleick , The Information: A History, a Theory, a Flood This chart is a canonical plot of seven distinct positive, negative, and neutral stock momentum grou… read more...

Weekly Insider Trading

via: SeekingAlpha at 2017-12-23 01:44:32:000

Introduction Weekly Insider Trading from G-Stock is the result of quantitative screening of insider trading coupled with qualitative checks to produce a list of companies with the most interesting cues. The screening process starts by looking at number and value of insider trades, if sprea… read more...

Weekly Insider Trading

via: SeekingAlpha at 2017-12-23 01:44:32:000

Introduction Weekly Insider Trading from G-Stock is the result of quantitative screening of insider trading coupled with qualitative checks to produce a list of companies with the most interesting cues. The screening process starts by looking at number and value of insider trades, if sprea… read more...

Weekly Insider Trading

via: SeekingAlpha at 2017-12-23 01:44:32:000

Introduction Weekly Insider Trading from G-Stock is the result of quantitative screening of insider trading coupled with qualitative checks to produce a list of companies with the most interesting cues. The screening process starts by looking at number and value of insider trades, if sprea… read more...

Weekly Insider Trading

via: SeekingAlpha at 2017-12-23 01:44:32:000

Introduction Weekly Insider Trading from G-Stock is the result of quantitative screening of insider trading coupled with qualitative checks to produce a list of companies with the most interesting cues. The screening process starts by looking at number and value of insider trades, if sprea… read more...

Weekly Insider Trading

via: SeekingAlpha at 2017-12-23 01:44:32:000

Introduction Weekly Insider Trading from G-Stock is the result of quantitative screening of insider trading coupled with qualitative checks to produce a list of companies with the most interesting cues. The screening process starts by looking at number and value of insider trades, if sprea… read more...

ADMA files BLA for its third plasma collection center

via: SeekingAlpha at 2017-12-11 07:37:31:000

ADMA Biologics (NASDAQ: ADMA ) announces the filing of a Biologics License Application (BLA) for its third plasma collection center located in Kennesaw, Georgia. More news on: ADMA Biologics Inc, Healthcare stocks news, Read more … read more...

ADMA files BLA for its third plasma collection center

via: SeekingAlpha at 2017-12-11 07:37:31:000

ADMA Biologics (NASDAQ: ADMA ) announces the filing of a Biologics License Application (BLA) for its third plasma collection center located in Kennesaw, Georgia. More news on: ADMA Biologics Inc, Healthcare stocks news, Read more … read more...

ADMA files BLA for its third plasma collection center

via: SeekingAlpha at 2017-12-11 07:37:31:000

ADMA Biologics (NASDAQ: ADMA ) announces the filing of a Biologics License Application (BLA) for its third plasma collection center located in Kennesaw, Georgia. More news on: ADMA Biologics Inc, Healthcare stocks news, Read more … read more...

ADMA files BLA for its third plasma collection center

via: SeekingAlpha at 2017-12-11 07:37:31:000

ADMA Biologics (NASDAQ: ADMA ) announces the filing of a Biologics License Application (BLA) for its third plasma collection center located in Kennesaw, Georgia. More news on: ADMA Biologics Inc, Healthcare stocks news, Read more … read more...

ADMA files BLA for its third plasma collection center

via: SeekingAlpha at 2017-12-11 07:37:31:000

ADMA Biologics (NASDAQ: ADMA ) announces the filing of a Biologics License Application (BLA) for its third plasma collection center located in Kennesaw, Georgia. More news on: ADMA Biologics Inc, Healthcare stocks news, Read more … read more...

ADMA Biologics: Can We Trust This ~$3 Biotech Stock Again?

via: SeekingAlpha at 2017-11-27 11:40:34:000

"How much easier it is to be critical than to be correct." - Benjamin Disraeli Today, we revisit a name I have not profiled in quite some time. However, it has seen additional insider buying in recent weeks and I have gotten a few inquiries from followers on it so far in November Compan… read more...

ADMA Biologics: Can We Trust This ~$3 Biotech Stock Again?

via: SeekingAlpha at 2017-11-27 11:40:34:000

"How much easier it is to be critical than to be correct." - Benjamin Disraeli Today, we revisit a name I have not profiled in quite some time. However, it has seen additional insider buying in recent weeks and I have gotten a few inquiries from followers on it so far in November Compan… read more...

ADMA Biologics: Can We Trust This ~$3 Biotech Stock Again?

via: SeekingAlpha at 2017-11-27 11:40:34:000

"How much easier it is to be critical than to be correct." - Benjamin Disraeli Today, we revisit a name I have not profiled in quite some time. However, it has seen additional insider buying in recent weeks and I have gotten a few inquiries from followers on it so far in November Compan… read more...

ADMA Biologics: Can We Trust This ~$3 Biotech Stock Again?

via: SeekingAlpha at 2017-11-27 11:40:34:000

"How much easier it is to be critical than to be correct." - Benjamin Disraeli Today, we revisit a name I have not profiled in quite some time. However, it has seen additional insider buying in recent weeks and I have gotten a few inquiries from followers on it so far in November Compan… read more...

ADMA Biologics: Can We Trust This ~$3 Biotech Stock Again?

via: SeekingAlpha at 2017-11-27 11:40:34:000

"How much easier it is to be critical than to be correct." - Benjamin Disraeli Today, we revisit a name I have not profiled in quite some time. However, it has seen additional insider buying in recent weeks and I have gotten a few inquiries from followers on it so far in November Compan… read more...

Your Daily Pharma Scoop: Gilead CAR-T Potential, Egalet Surges, Aerie Launches Mid-Stage Study

via: SeekingAlpha at 2017-11-17 09:31:22:000

This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Gilead Sciences Today we will discuss… read more...

Your Daily Pharma Scoop: Gilead CAR-T Potential, Egalet Surges, Aerie Launches Mid-Stage Study

via: SeekingAlpha at 2017-11-17 09:31:22:000

This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Gilead Sciences Today we will discuss… read more...

Your Daily Pharma Scoop: Gilead CAR-T Potential, Egalet Surges, Aerie Launches Mid-Stage Study

via: SeekingAlpha at 2017-11-17 09:31:22:000

This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Gilead Sciences Today we will discuss… read more...

Your Daily Pharma Scoop: Gilead CAR-T Potential, Egalet Surges, Aerie Launches Mid-Stage Study

via: SeekingAlpha at 2017-11-17 09:31:22:000

This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Gilead Sciences Today we will discuss… read more...

Your Daily Pharma Scoop: Gilead CAR-T Potential, Egalet Surges, Aerie Launches Mid-Stage Study

via: SeekingAlpha at 2017-11-17 09:31:22:000

This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Gilead Sciences Today we will discuss… read more...

Daily Insider Ratings Round Up 11/13/17: ADMA, S

via: SeekingAlpha at 2017-11-15 12:45:34:000

InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "… read more...

Daily Insider Ratings Round Up 11/13/17: ADMA, S

via: SeekingAlpha at 2017-11-15 12:45:34:000

InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "… read more...

Daily Insider Ratings Round Up 11/13/17: ADMA, S

via: SeekingAlpha at 2017-11-15 12:45:34:000

InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "… read more...

Daily Insider Ratings Round Up 11/13/17: ADMA, S

via: SeekingAlpha at 2017-11-15 12:45:34:000

InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "… read more...

Daily Insider Ratings Round Up 11/13/17: ADMA, S

via: SeekingAlpha at 2017-11-15 12:45:34:000

InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "… read more...

Your Daily Pharma Scoop: Heron Undervalued, Theravance Submits NDA, Nektar Continues To Surge

via: SeekingAlpha at 2017-11-14 12:14:39:000

This abridged "Daily Scoop" is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Heron Therapeutics Today we will discuss an article … read more...

Your Daily Pharma Scoop: Heron Undervalued, Theravance Submits NDA, Nektar Continues To Surge

via: SeekingAlpha at 2017-11-14 12:14:39:000

This abridged "Daily Scoop" is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Heron Therapeutics Today we will discuss an article … read more...

Your Daily Pharma Scoop: Heron Undervalued, Theravance Submits NDA, Nektar Continues To Surge

via: SeekingAlpha at 2017-11-14 12:14:39:000

This abridged "Daily Scoop" is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Heron Therapeutics Today we will discuss an article … read more...

Your Daily Pharma Scoop: Heron Undervalued, Theravance Submits NDA, Nektar Continues To Surge

via: SeekingAlpha at 2017-11-14 12:14:39:000

This abridged "Daily Scoop" is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Heron Therapeutics Today we will discuss an article … read more...

Your Daily Pharma Scoop: Heron Undervalued, Theravance Submits NDA, Nektar Continues To Surge

via: SeekingAlpha at 2017-11-14 12:14:39:000

This abridged "Daily Scoop" is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Heron Therapeutics Today we will discuss an article … read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2017-11-14 08:03:32:000

Sucampo Pharmaceuticals (NASDAQ: SCMP ) initiated with Buy rating and $14 (36% upside) price target by B. Riley. More news on: Sucampo Pharmaceuticals, Inc., TG Therapeutics, Inc., Perrigo Company, Healthcare stocks news, Stocks on the move, Read more … read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2017-11-14 08:03:32:000

Sucampo Pharmaceuticals (NASDAQ: SCMP ) initiated with Buy rating and $14 (36% upside) price target by B. Riley. More news on: Sucampo Pharmaceuticals, Inc., TG Therapeutics, Inc., Perrigo Company, Healthcare stocks news, Stocks on the move, Read more … read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2017-11-14 08:03:32:000

Sucampo Pharmaceuticals (NASDAQ: SCMP ) initiated with Buy rating and $14 (36% upside) price target by B. Riley. More news on: Sucampo Pharmaceuticals, Inc., TG Therapeutics, Inc., Perrigo Company, Healthcare stocks news, Stocks on the move, Read more … read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2017-11-14 08:03:32:000

Sucampo Pharmaceuticals (NASDAQ: SCMP ) initiated with Buy rating and $14 (36% upside) price target by B. Riley. More news on: Sucampo Pharmaceuticals, Inc., TG Therapeutics, Inc., Perrigo Company, Healthcare stocks news, Stocks on the move, Read more … read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2017-11-14 08:03:32:000

Sucampo Pharmaceuticals (NASDAQ: SCMP ) initiated with Buy rating and $14 (36% upside) price target by B. Riley. More news on: Sucampo Pharmaceuticals, Inc., TG Therapeutics, Inc., Perrigo Company, Healthcare stocks news, Stocks on the move, Read more … read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided for free by IEX